Benzofuranyl Derivatives
AssigneePfizer Inc.
InventorsJeffrey Allen Pfefferkorn, Anthony Lai Ling
Life of this patent
Estimating the term…
Abstract
The present invention provides compounds of Formula (I) that act as glucokinase activators; pharmaceutical compositions thereof; and methods of treating diseases, disorders, or conditions mediated by glucokinase.
Claims2
A method for treating Type H diabetes in a human comprising the step of administering to the human in need of such treatment a therapeutically effective amount of N,N-dimethyl-5-(2-methyl-6-((5-methylpyrazin-2-yl)carbamoyl)benzofuran-4-yloxy)pyrimidine-2-carboxamide or a pharmaceutically acceptable salt thereof.
A method for treating obesity in a human comprising the step of administering to the human in need of such treatment a therapeutically effective amount of N,N-dimethyl-5-(2-methyl-6-((5-methylpyrazin-2-yl)carbamoyl)benzofuran-4-yloxy)pyrimidine-2-carboxamide or a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.